Cell and Gene Therapy 21/10/2019 [WEBINAR] Is a non-viral gene editing approach the answer to... Exploring the next generation of non-viral gene-editing technologies, in partnership with Avectas
Cell and Gene Therapy 09/10/2019 Automation Special Interest Group: Report 2019 The 2019 Automation SIG identified some of the biggest opportunities to improve manufacturing efficiency and accuracy. This report comprises 14...
Cell and Gene Therapy 08/10/2019 [WEBINAR] Overcoming the shortages in cell and gene therapy... A panel of advanced therapy manufacturing experts explore strategies to overcome the global manufacturing shortage
Cell and Gene Therapy 07/10/2019 [Blog] Measuring success from conferences is getting harder, here&... A case study from the Business of Regenerative Medicine 2019
Cell and Gene Therapy 07/10/2019 60 seconds with... Dr Angela Colbert, Knight Vice President Education at the Frost Science Museum, Miami
Cell and Gene Therapy 25/09/2019 Functionality of non-virally transfected T cells A summary of Dr Shirley O'Dea's presentation and data from Phacilitate Leaders Europe
Cell and Gene Therapy 12/09/2019 60 Seconds with...Frances Pang, Orchard Therapeutics Frances Pang, VP Global Market Access at Orchard Therapeutics on evolving access and reimbursement structures, HTA engagement and commercial success
Cell and Gene Therapy 03/09/2019 60 Seconds with...Pilar Pinilla-Dominguez, NICE Pilar Pinilla-Dominguez, Senior Scientific Adviser at NICE on reimbursement models for advanced therapies
Cell and Gene Therapy 30/08/2019 Space is the Next Frontier for Global Pharma Episode six with Jana Stoudemire, Chief Commercialisation Officer, Space Tango
Cell and Gene Therapy 30/08/2019 The Next Generation of Gene Therapy: A Panoramic View of the New... Episode five with Jessica Carmen, Consultant, Pullan Consulting
Cell and Gene Therapy 22/08/2019 Breaking New Ground: The Why Behind the Nurse Educator Playbook Episode four with Linda S. Barnes, Principal, Linda S. Barnes Consulting
Cell and Gene Therapy 06/08/2019 Advanced Therapies Opportunities in Europe An overview of clinical, investment and market approval activity in Europe
Cell and Gene Therapy 01/08/2019 Translating Scientific and Technology Innovations from Academic... An unmissable interview with Dr Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania
Cell and Gene Therapy 03/07/2019 How an Italian Start-up Became the First Company to File a... Episode three with Dr Luca Alberici, Chief Business Officer, MolMed
Cell and Gene Therapy 25/06/2019 Technology Review: Gene Editing Edition one of Phacilitate’s technology review series examines gene editing approaches by viral and non-viral methods and where to access ...
